Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 1
This trial is looking at a new drug called NUC-1031 with carboplatin to treat ovarian cancer that has come back after treatment. The trial is for women who have ovarian cancer that has come back after initially responding to
The trial is for women who have
These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all of these.
Recruitment start: 30 November 2014
Recruitment end: 23 January 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sarah Blagden
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Imperial College Healthcare NHS Trust
NuCana Biomed Ltd
Last reviewed: 15 Aug 2017
CRUK internal database number: 12585
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
